Candel Therapeutics, Inc.
CADL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $103 | $35 | $70 | $83 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $2 | $2 |
| Total Curr. Assets | $104 | $37 | $72 | $85 |
| Property Plant & Equip (Net) | $3 | $4 | $5 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $1 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $4 | $7 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $107 | $41 | $79 | $89 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $2 |
| Short-Term Debt | $10 | $9 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $27 | $4 | $5 | $4 |
| Total Curr. Liab. | $38 | $14 | $6 | $5 |
| LT Debt | $3 | $13 | $22 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $1 | $0 |
| Other NC Liab. | $0 | $1 | $2 | $19 |
| Total NC Liab. | $3 | $14 | $25 | $20 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $0 |
| Total Liabilities | $41 | $28 | $31 | $25 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $89 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$192 | -$137 | -$99 | -$80 |
| AOCI | -$0 | $0 | $0 | -$89 |
| Other Equity | $258 | $149 | $147 | $144 |
| Total Equity | $66 | $13 | $48 | $64 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $107 | $41 | $79 | $89 |
| Net Debt | -$89 | -$13 | -$47 | -$82 |